Characteristics of peripheral immune response induced by large-vessel occlusion in patients with acute ischemic stroke

Front Neurol. 2024 Dec 10:15:1512720. doi: 10.3389/fneur.2024.1512720. eCollection 2024.

Abstract

Introduction: Despite improvements in the treatment of acute ischemic stroke (AIS), some patients still suffer from functional impairments, indicating the poor understanding of pathophysiologic process of AIS. Inflammation plays an important role in the pathophysiology of AIS. The purpose of the study was to investigate the peripheral inflammation in different subtypes of AIS.

Methods: Here, retrospective data from AIS with large vessel occlusion (LVO) and small vessel occlusion (SVO), and healthy controls, were initially analyzed. Then, flow cytometry was performed to evaluate the levels of peripheral naïve and memory T-cells. Finally, we characterized the T cell receptors (TCR) repertoire using high-throughput sequencing.

Results: Elevated levels of leukocytes, neutrophils, and neutrophil-to-lymphocyte ratio (NLR), and decreased levels of lymphocytes were found in LVO group than that in SVO group, which were correlated with the severity of LVO. In addition, higher percentages of both effector memory (Tem) and central memory (Tcm) T cells, and lower percentage of naïve T cells in CD4+ and CD8+ T cells, were found in LVO group than that in SVO and healthy groups. Moreover, impaired TCR diversity, and different abundances of V-J gene combinations and amino acid sequences, were found in LVO as compared with healthy group, which would be potential biomarkers for LVO diagnosis.

Discussion: In conclusion, AIS with LVO can rapidly induce peripheral immune response, which provides new insight into the understanding of pathophysiology of AIS.

Keywords: CD45; T cell; T cell receptors repertoire; acute ischemic stroke; large vessel occlusion.

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This study was supported by the Natural Science Foundation of Shandong Province (grant number ZR2021MH044 and ZR2023MH353), the National Natural Science Foundation of China (grant number 81701169), the Postdoctoral Innovation Project of Shandong Province (grant number SDCX-ZG-202302030), the China Postdoctoral Science Foundation (grant number 2019 M652398), and the Jinan Clinical Medicine Science and Technology Innovation Plan (grant number 202328062).